Skip to main content
Access Resources

MJFF Publications

3931 - 3940 of 7616 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • RESTRICTED
    Title: Meta-Analysis of the Alzheimer’s Disease Human Brain Transcriptome and Functional Dissection in Mouse Models
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2020.107908
    Citation Count: 201
  • RESTRICTED
    Title: Motor outcomes and adverse effects of deep brain stimulation for dystonic tremor: A systematic review
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.008
    Best OA location URL:
    Citation Count: 12
  • RESTRICTED
    Title: New hopes for disease modification in Parkinson's Disease
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2020.108085
    Citation Count: 25
  • RESTRICTED
    Title: Not only loud but also intelligible
    Journal Name: eClinicalMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.eclinm.2020.100456
    Citation Count: 1
  • RESTRICTED
    Title: Parkinson's disease motor subtype changes during 20 years of follow-up
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.024
    Citation Count: 22
  • RESTRICTED
    Title: Pharmacokinetic profile of the selective 5-HT3 receptor antagonist ondansetron in the rat: an original study and a minireview of the behavioural pharmacological literature in the rat
    Journal Name: Canadian Journal of Physiology and Pharmacology
    Publisher: Canadian Science Publishing
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1139/cjpp-2019-0551
    Best OA location URL:
    Citation Count: 7
  • OPEN
    Title: Proteomic analysis of transitional cell carcinoma–like variant of tubo-ovarian high-grade serous carcinoma
    Journal Name: Human Pathology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.humpath.2020.02.006
    Citation Count: 3
  • RESTRICTED
    Title: Reversible orolingual dyskinesia in a case of juvenile onset psychosis and cognitive decline: Expert commentary
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.015
    Best OA location URL:
    Citation Count: 1
  • RESTRICTED
    Title: Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30136-8
    Best OA location URL:
    Citation Count: 85
  • RESTRICTED
    Title: Snca-GFP Knock-In Mice Reflect Patterns of Endogenous Expression and Pathological Seeding
    Journal Name: eneuro
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1523/eneuro.0007-20.2020
    Citation Count: 15
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.